Literature DB >> 2312152

Osteoblast-like cell line maintains in vitro rat peritoneal mast cell viability and functional activity.

F Levi-Schaffer1, Z Bar-Shavit.   

Abstract

We studied the ability of the rat osteosarcoma derived cell-line with osteoblastic properties ROS-17/2.8 (ROS) to maintain in vitro rat peritoneal mast cells (MC) in a functional state. Highly purified (greater than 95%) MC were seeded on confluent ROS cells. The MC adhered tightly to the monolayers within a few hours and remained viable for at least 2 weeks, but did not proliferate. The MC retained their typical appearance, exhibiting highly granulated resting morphology when stained with alcian blue followed by safranin or with acidic toluidine blue. Furthermore, after 2 weeks, the MC were fully responsive to activation with compound 48/80 (3 micrograms/ml), releasing 75% of their histamine content, as compared to 3% in the absence of the secretagogue. Utilizing metabolically inactive ROS cells and prevention of contact between ROS and MC, we found that both release of factor(s) and cell-cell contact were required by ROS to exhibit their MC supporting activity. Various other cells and cell lines were unable to support MC viability. On the other hand, as demonstrated before, 3T3 fibroblasts were capable of promoting MC viability. Thus, MC viability and functional activity are specifically maintained by fibroblastic and osteoblastic cells. The abundance of MC in bone, and their participation in bone remodelling raise the possibility of physiological and pathological significance to interactions between MC and osteoblasts.

Entities:  

Mesh:

Year:  1990        PMID: 2312152      PMCID: PMC1385734     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  16 in total

1.  The mast cell-committed progenitor. I. Description of a cell capable of IL-3-independent proliferation and differentiation without contact with fibroblasts.

Authors:  D L Jarboe; J S Marshall; T R Randolph; A Kukolja; T F Huff
Journal:  J Immunol       Date:  1989-04-01       Impact factor: 5.422

2.  Bone-marrow mast cells in osteoporosis of aging.

Authors:  B Frame; R K Nixon
Journal:  N Engl J Med       Date:  1968-09-19       Impact factor: 91.245

Review 3.  The mast cell and bone.

Authors:  M J McKenna; B Frame
Journal:  Clin Orthop Relat Res       Date:  1985-11       Impact factor: 4.176

4.  Role of osteoblasts in hormonal control of bone resorption--a hypothesis.

Authors:  G A Rodan; T J Martin
Journal:  Calcif Tissue Int       Date:  1981       Impact factor: 4.333

5.  Saccharides mediate the attachment of rat macrophages to bone in vitro.

Authors:  Z Bar-Shavit; S L Teitelbaum; A J Kahn
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

6.  Fibroblasts maintain the phenotype and viability of the rat heparin-containing mast cell in vitro.

Authors:  F Levi-Schaffer; K F Austen; J P Caulfield; A Hein; W F Bloes; R L Stevens
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

7.  Glucocorticoid regulation of alkaline phosphatase in the osteoblastic osteosarcoma cell line ROS 17/2.8.

Authors:  R J Majeska; B C Nair; G A Rodan
Journal:  Endocrinology       Date:  1985-01       Impact factor: 4.736

8.  The effect of 1,25(OH)2D3 on alkaline phosphatase in osteoblastic osteosarcoma cells.

Authors:  R J Majeska; G A Rodan
Journal:  J Biol Chem       Date:  1982-04-10       Impact factor: 5.157

9.  Systemic mastocytosis associated with generalized osteopenia. Histopathological characterization of the skeletal lesion using undecalcified bone from two patients.

Authors:  M D Fallon; M P Whyte; S L Teitelbaum
Journal:  Hum Pathol       Date:  1981-09       Impact factor: 3.466

10.  Reversibility of vitamin D-induced human leukemia cell-line maturation.

Authors:  Z Bar-Shavit; A J Kahn; K R Stone; J Trial; T Hilliard; P H Reitsma; S L Teitelbaum
Journal:  Endocrinology       Date:  1986-02       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.